Skiplinks


Breadcrumb

Submitting comments on IQWiG's assessments

You can comment on intermediate stages of our reports and point out further aspects or missing data.

After the publication of report plans and preliminary reports, a commenting procedure is regularly conducted. You can also find information on current commenting procedures on our homepage and via the IQWiG info service.

Please only use the forms and guidelines available on the webpage of the respective IQWiG report for your comments.

Current commenting procedures (Hearings)

DeadlineTitle of commissionType of comment
2017-10-10Search for guidelines for the update of the DMP “coronary heart disease”on the preliminary report

Note: Commenting procedures are also conducted for early benefit assessments of drugs pursuant to AMNOG (dossier assessments), for assessments of the potential of non-drug interventions, and for the assessment according to §137h SGB V. However, these are not conducted by IQWiG, but by the Federal Joint Committee (G-BA). The G-BA’s website provides information on the commenting procedures for early benefit assessments of drugs, for assessments of the potential and testing of non-drug interventions, and for assessments according to §137h (German Version).


to top

Glossary entries